BACKGROUND/AIMS: Neuropsychiatric symptoms in Alzheimer's disease (AD) are highly prevalent. We sought to determine whether neuropsychiatric symptoms were related to global functional impairment at baseline and over a 3-year period in older normal control (NC), mild cognitive impairment (MCI) and mild AD dementia subjects. METHODS: Eight hundred and twelve subjects (229 NC, 395 MCI, 188 AD) from the Alzheimer's Disease Neuroimaging Initiative study underwent cognitive and behavioral assessments over 3 years. RESULTS: Greater hallucinations, anxiety and apathy were associated with greater global functional impairment at baseline, while the presence of hallucinations and apathy at baseline was associated with greater global functional impairment over time across all subjects. The following neuropsychiatric symptoms were not significantly associated with global functioning: delusions, agitation, depression, euphoria, disinhibition, irritability, aberrant motor behaviors, sleep and appetite. CONCLUSIONS: These results suggest that increased baseline hallucinations, apathy and anxiety are associated with current and future disease progression in AD.
BACKGROUND/AIMS: Neuropsychiatric symptoms in Alzheimer's disease (AD) are highly prevalent. We sought to determine whether neuropsychiatric symptoms were related to global functional impairment at baseline and over a 3-year period in older normal control (NC), mild cognitive impairment (MCI) and mild AD dementia subjects. METHODS: Eight hundred and twelve subjects (229 NC, 395 MCI, 188 AD) from the Alzheimer's Disease Neuroimaging Initiative study underwent cognitive and behavioral assessments over 3 years. RESULTS: Greater hallucinations, anxiety and apathy were associated with greater global functional impairment at baseline, while the presence of hallucinations and apathy at baseline was associated with greater global functional impairment over time across all subjects. The following neuropsychiatric symptoms were not significantly associated with global functioning: delusions, agitation, depression, euphoria, disinhibition, irritability, aberrant motor behaviors, sleep and appetite. CONCLUSIONS: These results suggest that increased baseline hallucinations, apathy and anxiety are associated with current and future disease progression in AD.
Authors: Patricia A Boyle; Paul F Malloy; Stephen Salloway; Deborah A Cahn-Weiner; Ronald Cohen; Jeffrey L Cummings Journal: Am J Geriatr Psychiatry Date: 2003 Mar-Apr Impact factor: 4.105
Authors: Liana G Apostolova; Gohar G Akopyan; Negar Partiali; Calen A Steiner; Rebecca A Dutton; Kiralee M Hayashi; Ivo D Dinov; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson Journal: Dement Geriatr Cogn Disord Date: 2007-06-14 Impact factor: 2.959
Authors: Yonas E Geda; David S Knopman; David A Mrazek; Gregory A Jicha; Glenn E Smith; Selamawit Negash; Bradley F Boeve; Robert J Ivnik; Ronald C Petersen; V Shane Pankratz; Walter A Rocca Journal: Arch Neurol Date: 2006-03
Authors: Adam P Mecca; Hannah R Michalak; Julia W McDonald; Emily C Kemp; Erika A Pugh; Melinda L Becker; Marcia C Mecca; Christopher H van Dyck Journal: Dement Geriatr Cogn Disord Date: 2018-06-08 Impact factor: 2.959
Authors: Nancy J Donovan; Rebecca E Amariglio; Amy S Zoller; Rebecca K Rudel; Teresa Gomez-Isla; Deborah Blacker; Bradley T Hyman; Joseph J Locascio; Keith A Johnson; Reisa A Sperling; Gad A Marshall; Dorene M Rentz Journal: Am J Geriatr Psychiatry Date: 2014-02-26 Impact factor: 4.105
Authors: Catherine E Munro; Nancy J Donovan; Brendan J Guercio; Sarah E Wigman; Aaron P Schultz; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2015-06 Impact factor: 21.566
Authors: Brendan J Guercio; Nancy J Donovan; Catherine E Munro; Sarah L Aghjayan; Sarah E Wigman; Joseph J Locascio; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; A Scott Winter; Meharvan Singh; Sid E O'Bryant Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: S Christine You; Christine M Walsh; Louis A Chiodo; Robin Ketelle; Bruce L Miller; Joel H Kramer Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Nancy J Donovan; Lauren P Wadsworth; Natacha Lorius; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall Journal: Am J Geriatr Psychiatry Date: 2013-07-24 Impact factor: 4.105